W. Schnitz

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

R. Moots, P. Emery, D. Mevorach, 2017, The Lancet.

Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus.

M. Reichlin, E. Koren, W. Schnitz, 1993, Arthritis and rheumatism.

Tophaceous gout with rare involvement of the patella

James Evans, W. Schnitz, N. Armstrong, 2016, Radiology Case Reports.

Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.

M. Reichlin, R. Scofield, I. Targoff, 1996, The Journal of rheumatology.